跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 1 g/vial - HSA Drug Approval Details
Approvals
/
HSA
/
GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 1 g/vial
Approved
THERAPEUTIC
GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 1 g/vial
Fresenius Kabi Oncology Limited
🇸🇬 Health Sciences Authority
Approval Date
Jan 25, 2016
Approval ID
08fbc9ce7f636c24
Company
Fresenius Kabi Oncology Limited
Type
Therapeutic
Approval Details
Approval Id
08fbc9ce7f636c24
Drug Name
GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 1 g/vial
Product Name
GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 1 g/vial
Approval Number
SIN14926P
Approval Date
2016-01-25
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BC05
Atc Item Name
gemcitabine
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
GEMCITABINE HYDROCHLORIDE EQV GEMCITABINE
1 g/vial
GEMCITABINE HYDROCHLORIDE EQV GEMCITABINE
1 G/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 25, 2016
Approval ID
08fbc9ce7f636c24
Type
Therapeutic
Back to HSA Approvals
